Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry.
AUTOR(ES)
Lennox, G
RESUMO
Diffuse Lewy body disease is an important pathological substrate of the common syndrome of parkinsonian dementia. The new technique of anti-ubiquitin immunocytochemistry has been used in a correlative quantitative neuropathological study of fifteen cases of diffuse Lewy body disease, showing that the severity of dementia is related to cortical Lewy body density, whilst subcortical abnormalities make a much less significant contribution. Cortical senile plaques also appear to be part of the pathology of diffuse Lewy body disease and should not therefore be used as an isolated diagnostic criterion for Alzheimer's disease. Diagnostic criteria for diffuse Lewy body disease are discussed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1031631Documentos Relacionados
- Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease.
- Diffuse Lewy body disease: clinical features in 15 cases.
- Diffuse Lewy body disease: clinical features in nine cases without coexistent Alzheimer's disease.
- Diffuse Lewy body disease presenting with a supranuclear gaze palsy.
- Tissue preparation for immunocytochemistry.
